cocaine has been researched along with Atherosclerotic Parkinsonism in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.86) | 18.7374 |
1990's | 17 (48.57) | 18.2507 |
2000's | 15 (42.86) | 29.6817 |
2010's | 1 (2.86) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Mavri, J; Pregeljc, D; Teodorescu-Perijoc, D; Umek, N; Vianello, R | 1 |
Lappin, JM; Sara, GE | 1 |
Asenbaum, S; Bencsits, G; Bloem, BR; Brücke, T; Gerschlager, W; Hoffmann, M; Pirker, W; Prayer, D; Zijlmans, JC | 1 |
Chung, HK; Jeon, B; Kim, HK; Kim, JM; Kim, JW; Kim, Y; Lee, CR; Lee, DS; Lee, JH; Yang, SO; Yoo, CI | 1 |
Kulak, JM; McIntosh, JM; Musachio, JL; Quik, M | 1 |
Decristoforo, C; Dierkes, K; Donnemiller, E; Kolbitsch, C; Oberladstätter, M; Poewe, W; Riccabona, G; Scherfler, C; Schocke, M; Wenning, G; Zschiegner, F | 1 |
Barthel, H; Collingridge, DR; Hermann, W; Hesse, S; Kluge, R; Sabri, O; Wagner, A | 1 |
Brownell, AL; McNaught, KS; Olanow, CW; Perl, DP | 1 |
Andringa, G; Bol, JG; Booij, J; de Bruin, K; Drukarch, B; Habraken, JB; Sorman, K | 1 |
Faherty, CJ; Lloyd, SA; Smeyne, RJ | 1 |
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W | 1 |
al-Tikriti, MS; Elsworth, JD; Innis, RB; Redmond, DE; Roth, RH; Sladek, JR; Taylor, JR | 1 |
Brownell, AL; Brownell, GL; Burns, L; Elmaleh, D; Hantraye, P; Pakzaban, P; Petto, AJ; Shoup, T; Spealman, RD; Wüllner, U | 1 |
Isacson, O | 1 |
Bauer, LO | 2 |
Hagiwara, M; Kano, T; Kiuchi, K; Shibuya, M; Suzuki, Y | 1 |
Brownell, AL; Brownell, GL; Elmaleh, DR; Fischman, AJ; Madras, BK; Meltzer, PC; Shoup, TM | 1 |
Babich, JW; Barrow, SA; Elmaleh, DR; Fischman, AJ; Hanson, RN; Madras, BK; Meltzer, P | 1 |
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
Booij, J; Tissingh, G; van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
Dhopesh, VP; Weddington, WW; Yagnik, PM | 1 |
Bettin, S; Dietrich, J; Kämpfer, I; Knapp, WH; Lössner, J; Reuter, M; Schäfer, A; Seese, A; Wagner, A | 1 |
Chang, YS; Jeon, B; Jeong, JM; Kim, JM; Kim, KM; Lee, DS; Lee, MC | 1 |
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F | 1 |
Brashear, A; Farlow, MR; Hutchins, GD; Mulholland, GK; Siemers, ER; Zheng, QH | 1 |
Fujita, M; Ito, Y; Kusuoka, H; Nishimura, T; Okada, T; Shimada, S; Tohyama, M; Watanabe, Y | 1 |
Friedman, JH; Goldstein, S; Innis, R; Marek, K; Seibyl, J | 1 |
Bohn, MC; Connor, B; Elsworth, JD; Kozlowski, DA; Schallert, T; Tillerson, JL; Unnerstall, JR | 1 |
Eising, EG; Müller, T; Peters, S; Przuntek, H | 1 |
Kulak, JM; McIntosh, JM; Polonskaya, Y; Quik, M | 1 |
Andersson, M; Cenci, MA; Konradi, C | 1 |
Snyder, SH | 1 |
Brownell, AL; Brownell, GL; Elmaleh, D; Hantraye, P; Isacson, O; Madras, BK; Spealman, RD; Wüllner, U | 1 |
Checkoway, H; Franklin, GM; Longstreth, WT; Powers, K; Smith-Weller, T; Swanson, PD | 1 |
3 review(s) available for cocaine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke | 2019 |
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism.
Topics: Benzamides; Brain; Cocaine; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Humans; Iodine Radioisotopes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Risk Factors; Tomography, Emission-Computed, Single-Photon | 1997 |
Vascular Parkinsonism: a case report and review of the literature.
Topics: Basal Ganglia Diseases; Cerebral Arteries; Cocaine; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2001 |
32 other study(ies) available for cocaine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study.
Topics: Amphetamine; Animals; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Humans; Methamphetamine; Models, Neurological; Parkinson Disease, Secondary; Reserpine; Synapses; Vesicular Neurotransmitter Transport Proteins | 2020 |
[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Female; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
Topics: Causality; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Male; Manganese; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Occupational Exposure; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed, Single-Photon | 2002 |
Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Azetidines; Brain Chemistry; Caudate Nucleus; Cocaine; Conotoxins; Neostriatum; Parkinson Disease, Secondary; Putamen; Radioligand Assay; Receptors, Nicotinic; Saimiri; Substantia Nigra | 2002 |
Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
Topics: Animals; Cell Count; Cocaine; Dopamine Plasma Membrane Transport Proteins; Magnetic Resonance Imaging; Male; Medial Forebrain Bundle; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Models, Anatomic; Neostriatum; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Radiopharmaceuticals; Rats; Rats, Wistar; Sympatholytics; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase | 2002 |
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
Topics: Adult; Benzamides; Brain Mapping; Cerebellum; Cocaine; Corpus Striatum; Dopamine; Female; Hepatolenticular Degeneration; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Psychometrics; Pyrrolidines; Reference Values; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2003 |
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Carbon Radioisotopes; Cocaine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dopamine Uptake Inhibitors; Hazardous Substances; Humans; Inclusion Bodies; Male; Molecular Structure; Multienzyme Complexes; Oligopeptides; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 2004 |
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2005 |
Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Cocaine; DNA Primers; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Immunohistochemistry; Mice; Parkinson Disease, Secondary; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography | 2008 |
Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Chlorocebus aethiops; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Fetal Tissue Transplantation; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra; Transplantation, Heterotopic; Transplantation, Homologous | 1994 |
Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Dopamine; Motor Activity; Nerve Endings; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed | 1994 |
Clinical and preclinical PET correlates of parkinsonism with 11C-WIN 35,428.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbon Radioisotopes; Cocaine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1994 |
Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Cerebellar Ataxia; Cocaine; Female; Humans; Male; Neurologic Examination; Parkinson Disease, Secondary; Postural Balance; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Cocaine-induced CREB phosphorylation and c-Fos expression are suppressed in Parkinsonism model mice.
Topics: Animals; Cocaine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Dopamine Uptake Inhibitors; Mice; Mice, Inbred C3H; Nerve Tissue Proteins; Parkinson Disease, Secondary; Phosphorylation; Proto-Oncogene Proteins c-fos; Rabbits | 1995 |
Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients.
Topics: Alcoholism; Basal Ganglia; Cocaine; Down-Regulation; Female; Humans; Male; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Tremor | 1996 |
Cocaine congeners as PET imaging probes for dopamine terminals.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carbon Radioisotopes; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Macaca fascicularis; Male; Nerve Endings; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1996 |
SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Carrier Proteins; Cocaine; Contrast Media; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Macaca mulatta; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Parkinson Disease; Parkinson Disease, Secondary; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |
Can cocaine abuse cause parkinsonism?
Topics: Adult; Brain Chemistry; Cocaine; Dopamine; Humans; Male; Matched-Pair Analysis; Middle Aged; Narcotics; Parkinson Disease, Secondary; Substance-Related Disorders | 1997 |
[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
Topics: Adult; Aged; Basal Ganglia; Benzamides; Carrier Proteins; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed | 1997 |
Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.
Topics: Adolescent; Adult; Brain Mapping; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neurologic Examination; Occipital Lobe; Parkinson Disease, Secondary; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 1998 |
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed | 1998 |
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
Topics: Adult; Aged; Brain Mapping; Carbon Radioisotopes; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Uptake Inhibitors; Dystonia; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed | 1999 |
Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.
Topics: Animals; Biological Transport; Brain; Carrier Proteins; Cocaine; Disease Models, Animal; Dopa Decarboxylase; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease, Secondary; Radioligand Assay; Rats; Rats, Wistar; Rotation; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1999 |
Hemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.
Topics: Adult; Biological Transport; Carrier Proteins; Caudate Nucleus; Cocaine; Corpus Striatum; Dopamine; Female; Humans; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Mesencephalon; Parkinson Disease, Secondary; Putamen; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2001 |
Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Topics: Aging; Animals; Autoradiography; Carrier Proteins; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Oxidopamine; Parkinson Disease, Secondary; Presynaptic Terminals; Rats; Rats, Inbred F344; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |
Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cocaine; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Habenula; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Neural Pathways; Neurons; Parkinson Disease, Secondary; Putamen; Pyridines; Receptors, Nicotinic; Saimiri; Substantia Nigra | 2001 |
cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
Topics: Animals; Antiparkinson Agents; Cocaine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Denervation; DNA; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Enkephalins; Female; Gene Expression; Levodopa; Oligonucleotides, Antisense; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor AP-1 | 2001 |
Biochemical factors in Schizophrenia.
Topics: Amphetamines; Animals; Binding Sites; Brain; Cocaine; Dopamine; Humans; Levodopa; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Disease Models, Animal; Dopamine; Immunohistochemistry; Macaca fascicularis; Motor Activity; Nerve Fibers; Parkinson Disease, Secondary; Radioligand Assay; Tomography, Emission-Computed | 1992 |
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.
Topics: Adult; Aged; Alcohol Drinking; Caffeine; Case-Control Studies; Coffee; Cola; Female; Humans; Male; Middle Aged; Odds Ratio; Parkinson Disease; Parkinson Disease, Secondary; Phosphodiesterase Inhibitors; Population Surveillance; Risk Assessment; Risk Factors; Smoking; Tea; Washington | 2002 |